cobas p 512 and cobas p 612 pre-analytical systems

Adapting to today’s needs. Flexible for tomorrow’s demand.

cobas-p-612-pre-analytical-system-thumbnail
Do you have any questions?
Contact us

Innovation

The optimal answer to face emerging challenges in laboratory operations, allowing for:

  • Upgradable to connected automation
  • Easy to add functionalities
  • Comprehensive inspection of sample quality
  • Increased productivity in the same footprint

 

Speed

 

High productivity without compromising space and safety:

  • Industry leading throughput in standalone automation with up to 1.400 tubes/hour

 

Quality comes first

 

 

cobas p 512 and cobas p 612 systems perform a comprehensive inspection of samples at an early stage, optimizing the lab workflow and enabling the best use of time and resources, including:

 

  • Tube type identification
  • Liquid level detection
  • Spin status detection, which identifies whether blood samples have been centrifuged or not 
  • Sample quality check, which enables detection of normal, hemolytic, lipemic and icteric samples

 

Flexibility

 

  • Adapts to the lab’s sample handling needs.
  • A solution that is compatible with all lab disciplines
  • Sorting areas adapted to your workflow to stay flexible
  • Single point of entry and bulk loading of tubes for convenient sample loading
  • Long walk-away time
cobas p 512 pre-analytical system

cobas p 512 pre-analytical system

cobas p 612 pre-analytical system

cobas p 612 includes aliquoting and barcode labelling of secondary tubes 

cobas p 512/612 pre-analytical systems- adapting to today’s needs. Flexible for tomorrow’s demand.

Thanks to the response of our customers, and the commitment to high quality standards, Roche presents the evolution of cobas p 512/612 pre-analytical systems. Adapting to today’s needs - flexible for tomorrow’s demand.

Swiss Red Cross and Roche Diagnostics

Blood banks have a crucial role in the safety of the blood supply, ensuring that donated blood is screened in a timely manner and is safe for use. The Swiss Red Cross in Bern together with Roche Diagnostics built a laboratory counting with cobas® 8800 new generation of molecular